Literature DB >> 25568351

LMP1 mediates multinuclearity through downregulation of shelterin proteins and formation of telomeric aggregates.

Valérie Lajoie1, Bruno Lemieux1, Bassem Sawan2, Daniel Lichtensztejn3, Zelda Lichtensztejn3, Raymund Wellinger4, Sabine Mai3, Hans Knecht5.   

Abstract

Hodgkin lymphoma (HL) and Burkitt lymphoma are both germinal center-derived B-cell lymphomas. To assess the consequences of permanent latent membrane protein 1 (LMP1) expression as observed in tumor cells of Epstein-Barr virus (EBV) -associated HL, we analyzed 3-dimensional (3D) telomere dynamics and measured the expression of shelterin proteins at the transcriptional and translational level and their topographic distribution in the EBV-negative Burkitt cell line BJAB stably transfected with an inducible LMP1 system. Stable LMP1 expression led to a highly significant increase of multinucleated cells, nuclear volume, and 3D telomeric aggregates when compared with the LMP1-suppressed BJAB controls. Most importantly, LMP1 induced a significant downregulation of the shelterin components TRF1, TRF2, and POT1 at the transcriptional and translational level, and this downregulation was reversed after resuppression of LMP1. In addition, as revealed by spectral karyotyping, LMP1 induced "outré" giant cells and hypoploid "ghost" cells. This LMP1-induced multinucleation was blocked upon LMP1-independent TRF2 expression. These results show that LMP1-dependent deregulation of telomere stability and nuclear organization via shelterin downregulation, in particular TRF2, favors chromosomal rearrangements. We speculate that telomeric aggregates and ongoing breakage-bridge-fusion cycles lead to disturbed cytokinesis and finally to multinuclearity, as observed in EBV-associated HL.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25568351      PMCID: PMC4424269          DOI: 10.1182/blood-2014-08-594176

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  54 in total

Review 1.  Persistence of the Epstein-Barr virus and the origins of associated lymphomas.

Authors:  David A Thorley-Lawson; Andrew Gross
Journal:  N Engl J Med       Date:  2004-03-25       Impact factor: 91.245

2.  Persistent telomere damage induces bypass of mitosis and tetraploidy.

Authors:  Teresa Davoli; Eros Lazzerini Denchi; Titia de Lange
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

3.  Hepatocytes with extensive telomere deprotection and fusion remain viable and regenerate liver mass through endoreduplication.

Authors:  Eros Lazzerini Denchi; Giulia Celli; Titia de Lange
Journal:  Genes Dev       Date:  2006-10-01       Impact factor: 11.361

4.  Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's lymphoma.

Authors:  Alexander Claviez; Markus Tiemann; Heike Lüders; Matthias Krams; Reza Parwaresch; Günther Schellong; Wolfgang Dörffel
Journal:  J Clin Oncol       Date:  2005-06-20       Impact factor: 44.544

5.  Alterations of centromere positions in nuclei of immortalized and malignant mouse lymphocytes.

Authors:  Rahul Sarkar; Amanda Guffei; Bart J Vermolen; Yuval Garini; Sabine Mai
Journal:  Cytometry A       Date:  2007-06       Impact factor: 4.355

6.  The 3D nuclear organization of telomeres marks the transition from Hodgkin to Reed-Sternberg cells.

Authors:  H Knecht; B Sawan; D Lichtensztejn; B Lemieux; R J Wellinger; S Mai
Journal:  Leukemia       Date:  2008-11-27       Impact factor: 11.528

7.  Epstein-Barr virus distribution in Hodgkin's disease in an unselected Swedish population.

Authors:  G Enblad; K Sandvej; C Sundström; G Pallesen; B Glimelius
Journal:  Acta Oncol       Date:  1999       Impact factor: 4.089

8.  Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populations.

Authors:  Sally L Glaser; Margaret L Gulley; Christina A Clarke; Theresa H Keegan; Ellen T Chang; Sarah J Shema; Fiona E Craig; Joseph A Digiuseppe; Ronald F Dorfman; Risa B Mann; Hoda Anton-Culver; Richard F Ambinder
Journal:  Int J Cancer       Date:  2008-10-01       Impact factor: 7.396

9.  Characteristics of Hodgkin's lymphoma after infectious mononucleosis.

Authors:  Henrik Hjalgrim; Johan Askling; Klaus Rostgaard; Stephen Hamilton-Dutoit; Morten Frisch; Jin-Song Zhang; Mette Madsen; Nils Rosdahl; Helle Bossen Konradsen; Hans H Storm; Mads Melbye
Journal:  N Engl J Med       Date:  2003-10-02       Impact factor: 91.245

10.  Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells.

Authors:  U Kapp; W C Yeh; B Patterson; A J Elia; D Kägi; A Ho; A Hessel; M Tipsword; A Williams; C Mirtsos; A Itie; M Moyle; T W Mak
Journal:  J Exp Med       Date:  1999-06-21       Impact factor: 14.307

View more
  22 in total

1.  Disruption of direct 3D telomere-TRF2 interaction through two molecularly disparate mechanisms is a hallmark of primary Hodgkin and Reed-Sternberg cells.

Authors:  Hans Knecht; Nathalie A Johnson; Tina Haliotis; Daniel Lichtensztejn; Sabine Mai
Journal:  Lab Invest       Date:  2017-04-24       Impact factor: 5.662

Review 2.  Non-canonical roles of canonical telomere binding proteins in cancers.

Authors:  Semih Can Akincilar; Claire Hian Tzer Chan; Qin Feng Ng; Kerem Fidan; Vinay Tergaonkar
Journal:  Cell Mol Life Sci       Date:  2021-02-18       Impact factor: 9.261

Review 3.  The lighthouse at the end of the chromosome.

Authors:  Yahya Benslimane; Lea Harrington
Journal:  F1000Res       Date:  2015-12-11

4.  Gene dosage reductions of Trf1 and/or Tin2 induce telomere DNA damage and lymphoma formation in aging mice.

Authors:  K Hartmann; A Illing; F Leithäuser; A Baisantry; L Quintanilla-Martinez; K L Rudolph
Journal:  Leukemia       Date:  2015-07-02       Impact factor: 11.528

Review 5.  Telomeres: Implications for Cancer Development.

Authors:  Aina Bernal; Laura Tusell
Journal:  Int J Mol Sci       Date:  2018-01-19       Impact factor: 5.923

Review 6.  LMP1 and Dynamic Progressive Telomere Dysfunction: A Major Culprit in EBV-Associated Hodgkin's Lymphoma.

Authors:  Hans Knecht; Sabine Mai
Journal:  Viruses       Date:  2017-06-27       Impact factor: 5.048

7.  Small and big Hodgkin-Reed-Sternberg cells of Hodgkin lymphoma cell lines L-428 and L-1236 lack consistent differences in gene expression profiles and are capable to reconstitute each other.

Authors:  Benjamin Rengstl; Sooji Kim; Claudia Döring; Christian Weiser; Julia Bein; Katrin Bankov; Marco Herling; Sebastian Newrzela; Martin-Leo Hansmann; Sylvia Hartmann
Journal:  PLoS One       Date:  2017-05-15       Impact factor: 3.240

8.  Super-resolution structure of DNA significantly differs in buccal cells of controls and Alzheimer's patients.

Authors:  Angeles Garcia; David Huang; Amanda Righolt; Christiaan Righolt; Maria Carmela Kalaw; Shubha Mathur; Elizabeth McAvoy; James Anderson; Angela Luedke; Justine Itorralba; Sabine Mai
Journal:  J Cell Physiol       Date:  2017-03-28       Impact factor: 6.384

9.  XPO1 Inhibition Preferentially Disrupts the 3D Nuclear Organization of Telomeres in Tumor Cells.

Authors:  Cheryl Taylor-Kashton; Daniel Lichtensztejn; Erkan Baloglu; William Senapedis; Sharon Shacham; Michael G Kauffman; Rami Kotb; Sabine Mai
Journal:  J Cell Physiol       Date:  2016-04-08       Impact factor: 6.384

10.  Transcription regulation of CDKN1A (p21/CIP1/WAF1) by TRF2 is epigenetically controlled through the REST repressor complex.

Authors:  Tabish Hussain; Dhurjhoti Saha; Gunjan Purohit; Anirban Kar; Anand Kishore Mukherjee; Shalu Sharma; Suman Sengupta; Parashar Dhapola; Basudeb Maji; Sreekanth Vedagopuram; Nobuko T Horikoshi; Nobuo Horikoshi; Raj K Pandita; Santanu Bhattacharya; Avinash Bajaj; Jean-François Riou; Tej K Pandita; Shantanu Chowdhury
Journal:  Sci Rep       Date:  2017-09-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.